Stem Cell Manufacturing Market
Number of pages: 100 | Report Format: PDF | Published date: April 24, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 12.58 billion |
|
Revenue Forecast in 2031 |
US$ 27.98 billion |
|
CAGR |
9.3% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global stem cell manufacturing market was valued at US$ 12.58 billion in 2022 and is expected to register a revenue CAGR of 9.3% to reach US$ 27.98 billion by 2031.
Stem Cell Manufacturing Market Fundamentals
With their unique capacity to differentiate into many specialized cell types, stem cells have enormous potential for changing medicine and regenerative treatments. Stem cells can be derived from various sources, including embryonic tissues, adult tissues, and induced pluripotent stem cells (iPSCs), and they can potentially treat a wide range of diseases and conditions, including cancer, neurodegenerative disorders, cardiovascular disease, and diabetes. As regenerative medicine expands, so does the need for stem cells and their derivatives, propelling the expansion of the stem cell manufacturing market.
Several trends and opportunities are influencing the stem cell manufacturing market. One of the most recent developments is the growing emphasis on establishing scalable and cost-effective manufacturing procedures for stem cells and their derivatives. With the potential for large-scale therapeutic applications, there is an increasing demand for efficient and reproducible technologies to manufacture high-quality stem cells in huge quantities while preserving their potency and safety.
Furthermore, automation and enhanced bioprocessing technologies are two trends growing the revenue share of the stem cell manufacturing market. Automation and bioprocessing technologies such as bioreactors, microcarriers, and 3D culture systems improve yield and product quality by streamlining manufacturing processes. These technologies also allow the creation of standardized and regulated manufacturing processes, which are critical for satisfying regulatory standards and guaranteeing product quality consistency.
[75675]
Stem Cell Manufacturing Market Dynamics
Regenerative medicine, which utilizes stem cells and their derivatives to repair, replace, or regenerate damaged tissues or organs, holds high potential for treating various diseases and conditions with unmet medical needs. As regenerative medicine continues to advance and gain recognition, the demand for stem cells and their derivatives for therapeutic applications is increasing, driving the growth of the stem cell manufacturing market revenue.
Technological improvements drive stem cell production, transforming stem cell creation, processing, and usage for therapeutic purposes. Bioprocessing technologies such as perfusion systems, bioreactors, and microcarrier-based culture systems have been created to maximize the generation of stem cells in large quantities. These technologies provide regulated settings for stem cells to develop, differentiate, and expand, enabling the production of stem cells for therapeutic purposes to be scaled up. Moreover, cryopreservation, the process of preserving cells at low temperatures, has advanced stem cell manufacturing by allowing for long-term storage of stem cells and their derivatives. Cryopreserved stem cells can be stored in cell banks, providing a valuable resource for researchers and physicians to access a consistent and standardized supply of stem cells for various applications.
Moreover, collaboration among top players is another potential driver for increasing the stem cell manufacturing market. For instance, in August 2022, AGC Biologics announced a collaboration with RoosterBio Inc., a human mesenchymal stem/stromal cells (hMSCs) source. According to the companies, the collaboration delivers an end-to-end solution for researching and manufacturing hMSCs and exosome therapies by combining RoosterBio's well-established cell and media products and process development services with AGC's cell and gene therapy manufacturing capabilities.
One of the major restraining factors for the stem cell manufacturing market is the high cost associated with the manufacturing process. Additionally, strict regulatory policies and ethical concerns related to the use of embryonic stem cells can hinder market revenue growth. Furthermore, the high cost associated with stem cell therapies and the lack of reimbursement policies in certain regions may limit the adoption of these treatments, particularly in developing countries.
Stem Cell Manufacturing Market Ecosystem
The global stem cell manufacturing market is analyzed from four perspectives: product, application, end-user, and region.
Stem Cell Manufacturing Market by Product
[97787]
Based on the product, the global stem cell manufacturing market is segmented into consumables, instruments, and stem cell lines.
The stem cell lines segment dominated the global stem cell manufacturing market with a high revenue share in 2022. This large revenue share is attributed to the increasing demand for stem cell therapies and the growing prevalence of chronic diseases. Additionally, advancements in technology for stem cell research and development are expected to further drive the growth of the stem cell lines segment in the forecast years. Moreover, the rise in government funding for stem cell research and the increasing number of clinical trials are also contributing to the growth of the stem cell manufacturing market. The segment is sub-segmented into mesenchymal stem cells (MSC), hematopoietic stem cells (HSC), embryonic stem cells (ESC), induced pluripotent stem cells (iPSC), neural stem cells (NSC), multipotent adult progenitor stem cells. Top stem cell manufacturing market players increasingly focus on developing MSC and iPSCs. MSCs are known for their potential to differentiate into various cell types, making them a promising candidate for regenerative medicine. On the other hand, iPSCs are generated by reprogramming adult cells. They can differentiate into any cell type in the body, making them a valuable tool for disease modeling and drug discovery.
The consumable and instrument segments are expected to increase in the forecast years. The consumables segment is expected to grow due to the increasing demand for reagents, media, and sera for stem cell culture. However, the instruments segment will grow due to the rising adoption of automated systems for stem cell manufacturing.
Stem Cell Manufacturing Market by Application
Based on application, the global stem cell manufacturing market is segmented into research applications, clinical applications, and cell & tissue banking applications. The clinical application segment is sub-segmented into autologous stem cell therapy and allogeneic stem cell therapy.
In 2022, the clinical application segment accounted for most of the global stem cell manufacturing market revenue share. This can be attributed to the increasing number of clinical trials and research studies conducted for stem cell therapy. Moreover, the rising prevalence of chronic diseases and growing demand for regenerative medicine are also driving the growth of this segment. Furthermore, stem cells in clinical applications have shown promising results in treating various conditions such as cancer, cardiovascular diseases, and neurological disorders, further fueling the demand for stem cell therapy. Autologous stem cell therapy involves using a patient's stem cells for treatment, while allogenic stem cell therapy uses stem cells from a donor. These therapies have shown promising results in treating various diseases and disorders. Moreover, Autologous stem cell therapy is preferred over allogenic stem cell therapy as it reduces the risk of rejection. However, allogeneic stem cell therapy is more readily available and may be used in some cases where the patient's stem cells are not viable.
Cell & tissue banking application refers to storing stem cells for future use in regenerative medicine. The growth of this segment is driven by the increasing prevalence of chronic diseases, rising awareness about the therapeutic potential of stem cells, and the growing demand for personalized medicine. Technological advancements in cell preservation and storage techniques also contribute to market revenue growth.
Stem Cell Manufacturing Market by Region
Based on the region, the global stem cell manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for most of the market revenue share for stem cell manufacturing in 2022. The presence of well-established healthcare infrastructure, increasing government initiatives, and growing investments in research and development activities are key factors driving North America's stem cell manufacturing market revenue growth. Moreover, the rising prevalence of chronic diseases and the increasing demand for regenerative medicines are expected to further boost market revenue growth in North America.
The Asia Pacific stem cell manufacturing market revenue is expected to rise during the forecast period. This revenue growth is due to the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. The increasing investment in research and development activities is also expected to further boost the market revenue growth.
Stem Cell Manufacturing Market Competitive Landscape
The stem cell manufacturing market is highly competitive due to the presence of several established players and the emergence of new companies. The key players focus on strategic collaborations, partnerships, and mergers & acquisitions to strengthen their market position and expand their product portfolio. In addition, the increasing demand for personalized medicine and regenerative therapies drives the growth of the stem cell manufacturing market, creating opportunities for established and new players to innovate and develop new products. As a result, the market is expected to experience significant revenue growth during the forecast period.
The prominent companies operating in the global stem cell manufacturing market with the largest revenue share are,
Stem Cell Manufacturing Market Recent Developments
The stem cell manufacturing market is expected to experience significant revenue growth due to the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. Additionally, technological advancements in stem cell research and development contribute to this market revenue expansion.
The global stem cell manufacturing market was valued at US$ 12.5 billion in 2022.
Some major strategies key market players adopt in the stem cell manufacturing market include mergers and acquisitions, collaborations, partnerships, and product launches. These strategies help companies to expand their market presence and strengthen their position in the competitive landscape.
The stem cell lines segment dominated the global stem cell manufacturing market with a high revenue share in 2022.
The global stem cell manufacturing market is expected to register a revenue CAGR of 9.38 % during the forecast period.
*Insights on financial performance are subject to the availability of information in the public domain